Primary Surgery for Ovarian Cancer

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 409-421

  Carter, Jonathan ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b SYDNEY CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902219075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50033-6     Document Type: Chapter

References (81)

1. J Childers, J Lang, E Surwit and K Hatch (1995) Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol 59 25-33.
2. J Childers, A Nasseri and E Surwit (1996) Laparoscopic management of suspicious adnexal masses. Am J Obstet Gynecol 175 1451-1459.
3. M Canis, J Pouly, A Wattiez, et al. (1997) Laparoscopic management of adnexal masses suspicious at ultrasound. Obstet Gynecol 89 679-683.
4. C Mayer, D Miller and T Ehlen (2001) Peritoneal implantation of squamous cell carcinoma following rupture of a dermoid cyst during laparoscopic removal. Gynecol Oncol 84 180-183.
5. B Ranney (1970) Iatrogenic spillage from benign cystic teratoma causing severe peritoneal granulomas and adhesions: Report of a case. Obstet Gynecol 35 562-564.
6. M Maiman, V Seltzer and J Boyce (1991) Laparoscopic excision of ovarian neoplasms subsequently found to be malignant. Obstet Gynecol 77 563-565.
7. R Young, D Decker and JT Wharton (1983) Staging laparotomy in early ovarian cancer. JAMA 250 3072-3076.
8. I Cass, A Li, C Runowicz, et al. (2001) Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol 80 56-61.
9. S Chen and L Lee (1983) Incidence of para-aortic and pelvic lymph node metastasis in epithelial carcinoma of the ovary. Gynecol Oncol 16 95-100.
10. M Piver, J Barlow and S Lele (1978) Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 52 100-108.
11. C Morrow (1992) Malignant and borderline epithelial tumors of ovary: Clinical features, staging, diagnosis, intraoperative assessment and review of management. M Coppleson, J Monaghan, C Morrow, M Mattersall (Eds) 2nd ed. Gynecologic Oncology vol 2 London: Churchill Livingstone 889-915.
12. L McGowan, L Lesher, H Norris and M Barnett (1985) Misstaging of ovarian cancer. Obstet Gynecol 65 568-572.
13. F Lecuru, P Desfeux, S Camatte, et al. (2002) Role of laparoscopy on staging and survival after early ovarian cancer [abstract]. Gynecol Oncol 84 505.
14. C Griffiths (1986) Surgery at the time of diagnosis in ovarian cancer. G Blackledge, K Chan (Eds) Management of Ovarian Cancer London: Butterworth 67-70.
15. D Griswold, F Chavel and W Wilcox (1968) Success and failure in the treatment of solid tumors. 1. Effects of cyclophosphamide (NSCO26271) on primary and metastatic plasmacytoma in the hamster. Cancer Chemother Rep 52 345-387.
16. W Hoskins and S Rubin (1991) Surgery in the treatment of patients with advanced ovarian cancer. Seminars in Oncology 18 213-221.
17. R Hunter, N Alexander and W Soutter (1992) Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 166 504-511.
18. P Wu, J Lang, R Huang, et al. (1989) Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. E Burghardt, J Monaghan (Eds) Bailliere's Clinical Obstetrics and Gynaecology, vol 3. Operative Treatment of Ovarian Cancer London: Bailliere Tindall 143-155.
19. P Wu, J Qu, J Lang, et al. (1986) Lymph node metastasis of ovarian cancer: A preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol 155 1103-1108.
20. E Burghardt, H Pickel, M Lahousen and H Stettner (1986) Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 155 315-319.
21. E Burghardt, F Girardi, M Lahousen, et al. (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40 103-106.
22. R Bristow, R Tomacruz, D Armstrong, et al. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 20 1248-1259.
23. S Eisenkop, N Spirtos, T Montag, et al. (1992) The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 47 203-209.
24. S Eisenkop, R Friedman and H Wang (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 69 103-108.
25. T Le, G Krepart, R Lotocki and M Heywood (1997) Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol 67 208-214.
26. M Bookman and J Berek (1992) Biologic and immunologic therapy of ovarian cancer. Hematol Oncol Clin North Am 6 941-965.
27. C Griffiths, L Parker and A Fuller (1979) Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 63 235-240.
28. G Omura, M Brady, H Homesley, et al. (1991) Long term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. J Clin Oncol 9 1138-1150.
29. N Hacker, J Berek, L Lagasse, et al. (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 61 413-420.
30. L Puls, R Carrasco, M Morrow and D Blackhurst (1997) Stage I ovarian cancer: Specialty-related differences in survival management. South Med J 90 1097-1100.
31. E Junor, D Hole, L McNulty, et al. (1999) Specialist gynaecologists and survival outcome in ovarian cancer: A Scottish national study of 1866 patients. Br J Obstet Gynaecol 106 1130-1136.
32. A Mayer, S Chambers, E Graves, et al. (1992) Ovarian cancer staging: Does it require a gynecologic oncologist. Gynecol Oncol 47 223-227.
33. M Prefontaine, A Gelfand, J Donovan and J Powell (1994) Reproducibility of tumor measurements in ovarian cancer: A study of interobserver variability. Gynecol Oncol 55 87-90.
34. A Covens (2000) A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 78 269-274.
35. N Hacker (Ed.) (1989) Controversial aspects of cytoreductive surgery in epithelial ovarian cancer. Bailliere's Clinical Obstetrics and Gynaecology, vol 3. Operative Treatment of Ovarian Cancer London: Bailliere Tindall
36. W Hoskins, B Bundy, J Thigpen and G Omura (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage in epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecol Oncol 47 159-166.
37. J Berek, N Hacker, L Lagasse and R Leuchter (1982) Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer. Gynecol Oncol 13 87-92.
38. M Webb (1989) Cytoreduction in ovarian cancer: Achievability and results. E Burghardt, J Monagham (Eds) Bailliere's Clinical Obstetrics and Gynaecology, vol 3. Operative Treatment of Ovarian Cancer London: Bailliere Tindall 83-94.
39. M Potter, E Partridge, K Hatch, et al. (1991) Primary surgical therapy of ovarian cancer: How much and when. Gynecol Oncol 40 195-200.
40. D van Geldere, P Fa-Si-Oen, L Noach, et al. (2002) Complications after colorectal surgery without mechanical bowel preparation. J Am Coll Surg 194 40-47.
41. A Heintz, N Hacker, JS Berek, et al. (1986) Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity. Obstet Gynecol 67 783-788.
42. T Onda, H Yoshikawa, H Yokota, et al. (1996) Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. Cancer 78 903-908.
43. N Spirtos, G Gross, J Freddo and S Ballon (1995) Cytoreductive surgery in advanced epithelial cancer of the ovary: The impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 56 345-352.
44. A Kolbenstvedt and P Kolstad (1976) The difficulties of complete pelvic lymph node dissection in radical hysterectomy for carcinoma of the cervix. Gynecol Oncol 4 244-258.
45. A Kolbenstvedt and P Kolstad (1974) Pelvic lymph node dissection under perioperative lymphographic control. Gynecol Oncol 2 39-59.
46. N Hacker (1995) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer—therapeutic advance or surgical folly? Gynecol Oncol 56 325-327.
47. D Allen, R Planner and P Grant (1992) Maximum effort in the management of ovarian cancer, including pelvic and paraaortic lymphadenectomy. Aust N Z J Obstet Gynaecol 32 50-53.
48. F Carnino, G Fuda, G Ciccone, et al. (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65 467-472.
49. C Scarabelli, A Gallo, M Visentin, et al. (1997) Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer 7 18-26.
50. P Benedetti, G Scambia, G Baiocchi, et al. (1991) Technique and feasibility of radical paraaortic and pelvic lymphadenectomy for gynecologic malignancies. A prospective study. Int J Gynecol Cancer 1 133-140.
51. F di Re, G Baiocchi, R Fontanelli, et al. (1996) Systemic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic significance of node metastases. Gynecol Oncol 62 360-365.
52. F Parazzini, G Valsecchi, G Bolis, et al. (1999) Pelvic and paraaortic lymph nodal status in advanced ovarian cancer and survival. Gynecol Oncol 74 7-11.
53. N Spirtos, S Eisenkop, J Schlaerth and S Ballon (2000) Second look laparotomy after modified posterior exenteration: Patterns of persistence and recurrence in patients with stage III and IV ovarian cancer. Am J Obstet Gynecol 182 1321-1327.
54. N Gillette-Cloven, R Burger, B Monk, et al. (2001) Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 193 626-632.
55. A Weber and A Kennedy (1994) The role of bowel resection in the primary surgical cytoreduction of carcinoma of the ovary. J Am Coll Surg 179 465-470.
56. C Scarabelli, A Gallo and S Franceschi (2000) Primary cytoreductive surgery with rectosigmoid resection for patients with advanced epithelial ovarian carcinoma. Cancer 88 389-397.
57. S Eisenkop, R Nalick and N Teng (1991) Modified posterior exenteration for ovarian cancer. Obstet Gynecol 78 879-885.
58. C Hudson and M Chir (1973) Surgical treatment of ovarian cancer. Gynecol Oncol 1 370-378.
59. R Hammond and C Houghton (1990) The role of bowel surgery in the primary treatment of epithelial ovarian cancer. Aust N Z J Obstet Gynaecol 30 166-169.
60. W Jaeger, S Ackermann, H Kessler, et al. (2001) The effect of bowel resection of survival in advanced epithelial ovarian cancer. Gynecol Oncol 83 286-291.
61. J Nicklin, L Copeland and R O'Toole (1995) Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol 58 244.
62. J Fiorica, M Hoffman, J LaPolla, et al. (1989) The management of diaphragmatic lesions in ovarian cancer. Obstet Gynecol 74 927-929.
63. C Morrow and J Curtin (1996) Gynecologic Cancer Surgery New York: Churchill Livingstone
64. E Brand and N Pearlman (1990) Electrosurgical debulking of ovarian cancer: A new technique using the argon beam coagulator. Gynecol Oncol 39 115-118.
65. G Deppe, V Malviya, G Boike and JJ Malone (1989) Use of Cavitron surgical aspirator for debulking of diaphragmatic metastases in patients with advanced ovarian carcinoma. Surg Gynecol Obstet 165 455-456.
66. P van Dam, W Tjalma, J Weyler, et al. (1996) Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: A prospective randomized trial. Am J Obstet Gynecol 174 943-950.
67. M Carney, J Lancaster, C Ford, et al. (2002) A population-based study of patterns of care for ovarian cancer: Who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 84 36-42.
68. M van der Burg, M van Lent, M Buyse, et al. (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 332 629-634.
69. S Vogl, M Pagano, B Kaplan, et al. (1983) Cisplatin based combination chemotherapy for advanced ovarian cancer: High overall response rate with curative potential only in women with small tumor burdens. Cancer 51 2024-2030.
70. G Delgado, D Oran and E Petrilli (1984) Stage III epithelial ovarian cancer: The role of maximal surgical reduction. Gynecol Oncol 18 293-298.
71. R Pohl, G Dallenbach-Hellweg, T Plugge and B Czernobilsky (1984) Prognostic parameters in patients with advanced ovarian malignant tumors. Eur J Gynecol Oncol 5 160-169.
72. P Conte, M Sertoli, M Bruzzone, et al. (1985) Cisplatin, methotrexate and 5-fluorouracil combination chemotherapy for advanced ovarian cancer. Gynecol Oncol 20 290-297.
73. J Posada, A Marantz, K Yeung, et al. (1985) The cyclophosphamide, hexamethylmelamine, 5-fluorouracil regimen in the treatment of advanced and recurrent ovarian cancer. Gynecol Oncol 20 23-31.
74. K Louie, R Ozols, C Myers, et al. (1986) Long term results of a cisplatin containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol 4 1579-1585.
75. J Redman, G Petroni, P Saigo, et al. (1986) Prognostic factors in advanced ovarian carcinoma. J Clin Oncol 4 515-523.
76. J Neijt, W ten Bokkel Juinink, M van der Burg, et al. (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma. J Clin Oncol 5 1157-1168.
77. J Hainsworth, W Grosh, L Burnett, et al. (1988) Advanced ovarian cancer: Long term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Ann Intern Med 108 165-170.
78. M Piver, S Lele, D Marchetti, et al. (1988) The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 6 983-989.
79. G Sutton, F Stehman, L Einhorn, et al. (1989) Ten year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma. J Clin Oncol 7 223-229.
80. K Bertelson (1990) Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study. Gynecol Oncol 38 203-209.
81. G Michel, P De Iaco, D Castaigne, et al. (1997) Extensive cytoreductive surgery in advanced ovarian carcinoma. Eur J Gynecol Oncol 18 9-15.